Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancerAgathe Dubuisson(Servier (France)), Vincent Lombardi(Servier (France))Frontiers in ImmunologyApril 7, 202510.3389/fimmu.2025.1548509Cited by 3SaveCiteExport RISWatch citationsRelated PapersIntestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer|Nature Medicine|2022|637Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization|Cell Death and Disease|2019|9